Transplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab.
Lick, Scott D
Transplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab. [electronic resource] - The Annals of thoracic surgery Oct 2011 - 1428-34 p. digital
Publication Type: Comparative Study; Journal Article
1552-6259
10.1016/j.athoracsur.2011.04.064 doi
Adult
Alemtuzumab
Antibodies--immunology
Antibodies, Monoclonal, Humanized--administration & dosage
Antibodies, Neoplasm--administration & dosage
Antineoplastic Agents--administration & dosage
Cardiopulmonary Bypass
Female
Follow-Up Studies
Graft Rejection--epidemiology
Graft Survival--immunology
Heart Transplantation--immunology
Heart-Assist Devices
Histocompatibility Testing
Humans
Incidence
Intraoperative Care
Male
Middle Aged
Plasmapheresis--methods
Retrospective Studies
Risk Factors
Survival Rate--trends
Texas--epidemiology
Young Adult
Transplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab. [electronic resource] - The Annals of thoracic surgery Oct 2011 - 1428-34 p. digital
Publication Type: Comparative Study; Journal Article
1552-6259
10.1016/j.athoracsur.2011.04.064 doi
Adult
Alemtuzumab
Antibodies--immunology
Antibodies, Monoclonal, Humanized--administration & dosage
Antibodies, Neoplasm--administration & dosage
Antineoplastic Agents--administration & dosage
Cardiopulmonary Bypass
Female
Follow-Up Studies
Graft Rejection--epidemiology
Graft Survival--immunology
Heart Transplantation--immunology
Heart-Assist Devices
Histocompatibility Testing
Humans
Incidence
Intraoperative Care
Male
Middle Aged
Plasmapheresis--methods
Retrospective Studies
Risk Factors
Survival Rate--trends
Texas--epidemiology
Young Adult